Hossain, M. J., Al-Mamun, M. & Islam, M. R. Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Sci Rep. 7(3), e (2024). (2004).
Federation, I. D. Diabetes Atlas, 10th edn: Brussels, Belgium: International Diabetes Federation. (2021).
Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2 (8), 634–647 (2014).
Google Scholar
Watkins, D. A. & Ali, M. K. Measuring the global burden of diabetes: implications for health policy, practice, and research. Lancet 402 (10397), 163–165 (2023).
Google Scholar
American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 47(Suppl 1), S20-s42. (2024).
Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 6 (5), 361–369 (2018).
Google Scholar
Anjana, R. M. et al. Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study. BMJ Open. Diabetes Res. Care, 8(1), e001506 (2020). https://doi.org/10.1136/bmjdrc-2020-001506
Google Scholar
Herder, C. et al. Differences in biomarkers of inflammation between novel subgroups of Recent-Onset diabetes. Diabetes 70 (5), 1198–1208 (2021).
Google Scholar
Prasad, R. B. et al. Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver. Diabetologia 65 (1), 65–78 (2022).
Google Scholar
Zaharia, O. P. et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol. 7 (9), 684–694 (2019).
Google Scholar
Wang, F. et al. Novel subgroups and chronic complications of diabetes in Middle-Aged and elderly chinese:a prospective cohort study. Front. Endocrinol. (Lausanne). 12, 802114 (2021).
Google Scholar
Veelen, A., Erazo-Tapia, E., Oscarsson, J. & Schrauwen, P. Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment? Mol. Metab. 46, 101158 (2021).
Google Scholar
Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372, n71 (2021).
Google Scholar
Wells, G. The Newcastle Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analysis. Proceedings of the Third Symposium on Systematic Reviews. England: Oxford. (2000).
DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin. Trials. 7 (3), 177–188 (1986).
Google Scholar
Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. Bmj 327 (7414), 557–560 (2003).
Google Scholar
Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (4), 1088–1101 (1994).
Google Scholar
Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. Bmj 315 (7109), 629–634 (1997).
Google Scholar
Fedotkina, O. et al. Novel reclassification of adult diabetes is useful to distinguish stages of β-Cell function linked to the risk of vascular complications: the DOLCE study from Northern Ukraine. Front. Genet. 12, 637945 (2021).
Google Scholar
Huang, J., Peng, X., Dong, K., Tao, J. & Yang, Y. The association between antidiabetic agents and leukocyte telomere length in the novel classification of type 2 diabetes mellitus. Gerontology 67 (1), 60–68 (2021).
Google Scholar
Li, X. et al. Validation of the Swedish diabetes Re-Grouping scheme in Adult-Onset diabetes in China. J. Clin. Endocrinol. Metab. 105 (10), dgaa524 (2020).
Google Scholar
Peng, X. et al. Roles of plasma leptin and resistin in novel subgroups of type 2 diabetes driven by cluster analysis. Lipids Health Dis. 21 (1), 7 (2022).
Google Scholar
Ratter-Rieck, J. M. et al. Leukocyte counts and T-Cell frequencies differ between novel subgroups of diabetes and are associated with metabolic parameters and biomarkers of inflammation. Diabetes 70 (11), 2652–2662 (2021).
Google Scholar
Tanabe, H. et al. Factors associated with risk of diabetic complications in novel Cluster-Based diabetes subgroups: A Japanese retrospective cohort study. J. Clin. Med. 9 (7), 2083 (2020).
Google Scholar
Xiong, X. F. et al. Identification of two novel subgroups in patients with diabetes mellitus and their association with clinical outcomes: A two-step cluster analysis. J. Diabetes Investig. 12 (8), 1346–1358 (2021).
Google Scholar
Landgraf, W. et al. Distribution and characteristics of newly-defined subgroups of type 2 diabetes in randomised clinical trials: post hoc cluster assignment analysis of over 12,000 study participants. Diabetes Res. Clin. Pract. 190, 110012 (2022).
Google Scholar
Saatmann, N. et al. Physical fitness and cardiovascular risk factors in novel diabetes subgroups. J. Clin. Endocrinol. Metab. 107 (4), 1127–1139 (2022).
Google Scholar
Song, X. et al. Clinical characteristics of inpatients with New-Onset diabetes mellitus in Eastern china: based on novel clustering analysis. Front. Endocrinol. (Lausanne). 13, 927661 (2022).
Google Scholar
Wang, J. et al. Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes. Diabetologia 65 (12), 2146–2156 (2022).
Google Scholar
Li, X. & Chen, H. Characteristics of glucolipid metabolism and complications in novel cluster-based diabetes subgroups: a retrospective study. Lipids Health Dis. 22 (1), 200 (2023).
Google Scholar
Wang, W. et al. Secondary analysis of newly diagnosed type 2 diabetes subgroups and treatment responses in the MARCH cohort. Diabetes Metab. Syndr. 18 (1), 102936 (2024).
Google Scholar
Werkman, N. C. C. et al. Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht study. Diabetologia 67 (4), 690–702 (2024).
Google Scholar
Sladek, R. The many faces of diabetes: addressing heterogeneity of a complex disease. Lancet Diabetes Endocrinol. 6 (5), 348–349 (2018).
Google Scholar
Bennett, P. H. Basis of the present classification of diabetes. Adv. Exp. Med. Biol. 189, 17–29 (1985).
Google Scholar
Bottazzo, G. F., Florin-Christensen, A. & Doniach, D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2 (7892), 1279–1283 (1974).
Google Scholar
Otani, T. et al. Age of onset and type of Japanese younger diabetics in Tokyo. Diabetes Res. Clin. Pract. 10 (3), 241–244 (1990).
Google Scholar
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2021. Diabetes Care. 44 (Suppl 1), S15–s33 (2021).
Google Scholar
Omori, Y. et al. Current status of pregnancy in diabetic women. A comparison of pregnancy in IDDM and NIDDM mothers. Diabetes Res. Clin. Pract. 24, 273–278 (1994). Suppl.
Google Scholar
Scott, C. R., Smith, J. M., Cradock, M. M. & Pihoker, C. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 100 (1), 84–91 (1997).
Google Scholar
Bennet, L. et al. Adult-onset diabetes in middle Eastern immigrants to sweden: novel subgroups and diabetic complications-The all new diabetes in Scania cohort diabetic complications and ethnicity. Diabetes Metab. Res. Rev. 37 (6), e3419 (2021).
Google Scholar
Zou, X., Zhou, X., Zhu, Z. & Ji, L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol. 7 (1), 9–11 (2019).
Google Scholar
Bloomgarden, Z. & Drexler, A. Diabetes phenotypes: beyond IDDM vs NIDDM. J. Diabetes. 11 (9), 698–699 (2019).
Google Scholar
Dziegielewska-Gesiak, S. & Stoltny, D. Muc-Wierzgon, M. Novel diabetes subgroups. Lancet Diabetes Endocrinol. 6 (6), 438–439 (2018).
Google Scholar
Ahlqvist, E., Prasad, R. B. & Groop, L. Subtypes of type 2 diabetes determined from clinical parameters. Diabetes 69 (10), 2086–2093 (2020).
Google Scholar
Dennis, J. M., Shields, B. M., Henley, W. E., Jones, A. G. & Hattersley, A. T. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 7 (6), 442–451 (2019).
Google Scholar
Ndumele, C. E. et al. Cardiovascular-Kidney-Metabolic health: A presidential advisory from the American heart association. Circulation 148 (20), 1606–1635 (2023).
Google Scholar
American Diabetes Association Professional Practice Committee. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care. 47(Suppl 1), S219-s230. (2024).
Yin, L., Zhang, D., Ren, Q., Su, X. & Sun, Z. Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study. Med. (Baltim). 99 (9), e19236 (2020).
Google Scholar
Liu, L. et al. Prevalence and risk factors of retinopathy in patients with or without metabolic syndrome: a population-based study in Shenyang. BMJ Open. 5 (12), e008855 (2015).
Google Scholar
American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care. 47(Suppl 1), S179-s218. (2024).